Global Spasticity Treatment Market- Industry Analysis- By Drug Therapy, Physical Therapy and Region, Growth, Segmentation and Forecast-2019-2027

Global Spasticity Treatment Market is expected to reach US$ 1.079 Bn. at a CAGR of 4.1 during the forecast period 2027.

Global Spasticity Treatment Market Introduction and Overview

Spasticity is a muscle control disorder that is characterized by tight or stiff muscles along with the inability to control those muscles. It is caused by an imbalance of signals from the Central Nervous System (CNS) to the muscles. This imbalance is mostly found in people with cerebral palsy, traumatic brain injury, and multiple sclerosis. The disorder can be diagnosed by symptoms such as increased muscle tone, abnormal posture, overactive reflexes, and pain. Increasing the popularity of physical therapy for treating Spasticity in the general public is driving the market growth. The advantages associated with physiotherapy are encouraging hospitals to invest in physiotherapy centers, thereby accelerating the market growth. Development of Stimulatory devices with advanced built-in technologies for treating Spasticity are boosting the market growth. Increasing awareness about the disorder and rise in healthcare expenditure are acting as catalysts for the market. On the other hand, the time required to gain results, adverse effects of drugs, inadequate reimbursement policies for the treatment and lack of availability of skilled professionals to treat the disorder are restraining the market from growing. The report covers the detailed analysis of Global Market for Spasticity Treatment with the classifications of the market based on drug therapy, Physical Therapy, and region. Analysis of past market dynamics from 2016 to 2019 is given in the report, which will help readers to benchmark the past trends with current market scenarios with the key players contribution in it. The report has profiled twenty-three key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. The growing healthcare infrastructure in each region is different and focus is given on the availability of advanced technology and new techniques. The report has come up with recommendations for a future hot spot in the APAC region. New research findings, funding policies for projects, and their impact on the Spasticity Treatment market are covered in the report.

Global Spasticity Treatment Market Segment Analysis

The segment for drug therapy is expected to grow up to $XX Mn in the forecast period. Oral medications relax a large number of muscles and the dosage of oral medications can be easily adjusted. Baclofen is considered the first line of treatment for spasticity. The oral form of this drug is rapidly absorbed and crosses the blood-brain barrier. Tizanidine often has been used in conjunction with other oral drugs, such as baclofen, for additive effects. Muscle weakness accompanying other drugs is not a problem with Tizanidine. Global Spasticity Treatment Market To know about the Research Methodology :- Request Free Sample Report

Global Spasticity Treatment Market segmentation

The global Spasticity Treatment market is segmented based on-

• Physical Therapy  Stretching  Strengthening Exercises • Drug Therapy  Baclofen  Diazepam  Tizanidine  Dantrolene

Scope of the report: Inquire before buying

Global Spasticity Treatment Market Regional insights

Global Spasticity Treatment Market1 North America is expected to contribute is expected to contribute a major share in the spasticity market, owing to increasing population, presence of major players in the region, and growing clinical trials. Well-developed healthcare infrastructure, government funding for drug development drives the spasticity market growth. Europe contributes to the second largest share with a significant rise in the spasticity cases. Technological advancements along with the adoption of new treatments are elevating the market. APAC market is primarily driven by the factors such as growing population, large patient pool, availability of new drugs and developing healthcare infrastructure.

Key players operating in the Global Spasticity Treatment Market

• Codman & Shurtleff Inc • Medtronic, Inc • InMed Pharmaceuticals, Inc • Ipsen • Orient Pharma Co, Ltd • Taj Pharmaceuticals • MediciNova, Inc • Sanofi • Genentech • F.Hoffmann-La Roche Ltd • GlaxoSmithKline plc • Allergan • Pfizer • UCB Pharma • Johnson & Johnson Services • Sun Pharmaceuticals • Novartis AG • Teva Pharmaceuticals • Merz Pharma • Revance Therapeutics • Acorda Therapeutics • Orient Pharma • GW Pharmaceuticals The objective of the report is to present a comprehensive analysis of the Global Spasticity Treatment Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Spasticity Treatment Market dynamics, structure by analysing the market segments and project the Global Spasticity Treatment Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Spasticity Treatment Market make the report investor’s guide.
Global Spasticity Treatment Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: SPASTICITY TREATMENT Market Size, By Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global SPASTICITY TREATMENT Market Analysis and Forecast 6.1. SPASTICITY TREATMENT Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global SPASTICITY TREATMENT Market Analysis and Forecast, By Physical Therapy 7.1. Introduction and Definition 7.2. Key Findings 7.3. SPASTICITY TREATMENT Market Value Share Analysis, By Physical Therapy 7.4. SPASTICITY TREATMENT Market Size (US$ Mn) Forecast, By Physical Therapy 7.5. SPASTICITY TREATMENT Market Analysis, By Physical Therapy 7.6. SPASTICITY TREATMENT Market Attractiveness Analysis, By Physical Therapy 8. Global SPASTICITY TREATMENT Market Analysis and Forecast, By Drug Therapy 8.1. Introduction and Definition 8.2. Key Findings 8.3. SPASTICITY TREATMENT Market Value Share Analysis, By Drug Therapy 8.4. SPASTICITY TREATMENT Market Size (US$ Mn) Forecast, By Drug Therapy 8.5. SPASTICITY TREATMENT Market Analysis, By Drug Therapy 8.6. SPASTICITY TREATMENT Market Attractiveness Analysis, By Drug Therapy 9. Global SPASTICITY TREATMENT Market Analysis, By Region 9.1. SPASTICITY TREATMENT Market Value Share Analysis, By Region 9.2. SPASTICITY TREATMENT Market Size (US$ Mn) Forecast, By Region 9.3. SPASTICITY TREATMENT Market Attractiveness Analysis, By Region 10. North America SPASTICITY TREATMENT Market Analysis 10.1. Key Findings 10.2. North America SPASTICITY TREATMENT Market Overview 10.3. North America SPASTICITY TREATMENT Market Value Share Analysis, By Physical Therapy 10.4. North America SPASTICITY TREATMENT Market Forecast, By Physical Therapy 10.4.1. Stretching 10.4.2. Strengthening Exercises 10.5. North America SPASTICITY TREATMENT Market Value Share Analysis, By Drug Therapy 10.6. North America SPASTICITY TREATMENT Market Forecast, By Drug Therapy 10.6.1. Baclofen 10.6.2. Diazepam 10.6.3. Tizanidine 10.6.4. Dantrolene 10.7. North America SPASTICITY TREATMENT Market Value Share Analysis, By Country 10.8. North America SPASTICITY TREATMENT Market Forecast, By Country 10.8.1. U.S. 10.8.2. Canada 10.8.3. Mexico 10.9. North America SPASTICITY TREATMENT Market Analysis, By Country 10.10. U.S. SPASTICITY TREATMENT Market Forecast, By Physical Therapy 10.10.1. Stretching 10.10.2. Strengthening Exercises 10.11. U.S. SPASTICITY TREATMENT Market Forecast, By Drug Therapy 10.11.1. Baclofen 10.11.2. Diazepam 10.11.3. Tizanidine 10.11.4. Dantrolene 10.12. Canada SPASTICITY TREATMENT Market Forecast, By Physical Therapy 10.12.1. Stretching 10.12.2. Strengthening Exercises 10.13. Canada SPASTICITY TREATMENT Market Forecast, By Drug Therapy 10.13.1. Baclofen 10.13.2. Diazepam 10.13.3. Tizanidine 10.13.4. Dantrolene 10.14. Mexico SPASTICITY TREATMENT Market Forecast, By Physical Therapy 10.14.1. Stretching 10.14.2. Strengthening Exercises 10.15. Mexico SPASTICITY TREATMENT Market Forecast, By Drug Therapy 10.15.1. Baclofen 10.15.2. Diazepam 10.15.3. Tizanidine 10.15.4. Dantrolene 10.16. North America SPASTICITY TREATMENT Market Attractiveness Analysis 10.16.1. By Physical Therapy 10.16.2. By Drug Therapy 10.17. PEST Analysis 10.18. Key Trends 10.19. Key Developments 11. Europe SPASTICITY TREATMENT Market Analysis 11.1. Key Findings 11.2. Europe SPASTICITY TREATMENT Market Overview 11.3. Europe SPASTICITY TREATMENT Market Value Share Analysis, By Physical Therapy 11.4. Europe SPASTICITY TREATMENT Market Forecast, By Physical Therapy 11.4.1. Stretching 11.4.2. Strengthening Exercises 11.5. Europe SPASTICITY TREATMENT Market Value Share Analysis, By Drug Therapy 11.6. Europe SPASTICITY TREATMENT Market Forecast, By Drug Therapy 11.6.1. Baclofen 11.6.2. Diazepam 11.6.3. Tizanidine 11.6.4. Dantrolene 11.7. Europe SPASTICITY TREATMENT Market Value Share Analysis, By Country 11.8. Europe SPASTICITY TREATMENT Market Forecast, By Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Sweden 11.8.7. CIS countries 11.8.8. Rest of Europe 11.9. Germany SPASTICITY TREATMENT Market Forecast, By Physical Therapy 11.9.1. Stretching 11.9.2. Strengthening Exercises 11.10. Germany SPASTICITY TREATMENT Market Forecast, By Drug Therapy 11.10.1. Baclofen 11.10.2. Diazepam 11.10.3. Tizanidine 11.10.4. Dantrolene 11.11. U.K. SPASTICITY TREATMENT Market Forecast, By Physical Therapy 11.11.1. Stretching 11.11.2. Strengthening Exercises 11.12. U.K. SPASTICITY TREATMENT Market Forecast, By Drug Therapy 11.12.1. Baclofen 11.12.2. Diazepam 11.12.3. Tizanidine 11.12.4. Dantrolene 11.13. France SPASTICITY TREATMENT Market Forecast, By Physical Therapy 11.13.1. Stretching 11.13.2. Strengthening Exercises 11.14. France SPASTICITY TREATMENT Market Forecast, By Drug Therapy 11.14.1. Baclofen 11.14.2. Diazepam 11.14.3. Tizanidine 11.14.4. Dantrolene 11.15. Italy SPASTICITY TREATMENT Market Forecast, By Physical Therapy 11.15.1. Stretching 11.15.2. Strengthening Exercises 11.16. Italy SPASTICITY TREATMENT Market Forecast, By Drug Therapy 11.16.1. Baclofen 11.16.2. Diazepam 11.16.3. Tizanidine 11.16.4. Dantrolene 11.17. Spain SPASTICITY TREATMENT Market Forecast, By Physical Therapy 11.17.1. Stretching 11.17.2. Strengthening Exercises 11.18. Spain SPASTICITY TREATMENT Market Forecast, By Drug Therapy 11.18.1. Baclofen 11.18.2. Diazepam 11.18.3. Tizanidine 11.18.4. Dantrolene 11.19. Sweden SPASTICITY TREATMENT Market Forecast, By Physical Therapy 11.19.1. Stretching 11.19.2. Strengthening Exercises 11.20. Sweden SPASTICITY TREATMENT Market Forecast, By Drug Therapy 11.20.1. Baclofen 11.20.2. Diazepam 11.20.3. Tizanidine 11.20.4. Dantrolene 11.21. CIS countries SPASTICITY TREATMENT Market Forecast, By Physical Therapy 11.21.1. Stretching 11.21.2. Strengthening Exercises 11.22. CIS countries SPASTICITY TREATMENT Market Forecast, By Drug Therapy 11.22.1. Baclofen 11.22.2. Diazepam 11.22.3. Tizanidine 11.22.4. Dantrolene 11.23. Rest of Europe SPASTICITY TREATMENT Market Forecast, By Physical Therapy 11.23.1. Stretching 11.23.2. Strengthening Exercises 11.24. Rest of Europe SPASTICITY TREATMENT Market Forecast, By Drug Therapy 11.24.1. Baclofen 11.24.2. Diazepam 11.24.3. Tizanidine 11.24.4. Dantrolene 11.25. Europe SPASTICITY TREATMENT Market Attractiveness Analysis 11.25.1. By Drug Therapy 11.25.2. By Physical Therapy 11.26. PEST Analysis 11.27. Key Trends 11.28. Key Developments 12. Asia Pacific SPASTICITY TREATMENT Market Analysis 12.1. Key Findings 12.2. Asia Pacific SPASTICITY TREATMENT Market Overview 12.3. Asia Pacific SPASTICITY TREATMENT Market Value Share Analysis, By Physical Therapy 12.4. Asia Pacific SPASTICITY TREATMENT Market Forecast, By Physical Therapy 12.4.1. Stretching 12.4.2. Strengthening Exercises 12.5. Asia Pacific SPASTICITY TREATMENT Market Value Share Analysis, By Drug Therapy 12.6. Asia Pacific SPASTICITY TREATMENT Market Forecast, By Drug Therapy 12.6.1. Baclofen 12.6.2. Diazepam 12.6.3. Tizanidine 12.6.4. Dantrolene 12.7. Asia Pacific SPASTICITY TREATMENT Market Value Share Analysis, By Country 12.8. Asia Pacific SPASTICITY TREATMENT Market Forecast, By Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. South Korea 12.8.5. Australia 12.8.6. ASEAN 12.8.7. Rest of Asia Pacific 12.9. Asia Pacific SPASTICITY TREATMENT Market Analysis, By Country 12.10. China SPASTICITY TREATMENT Market Forecast, By Physical Therapy 12.10.1. Stretching 12.10.2. Strengthening Exercises 12.11. China SPASTICITY TREATMENT Market Forecast, By Drug Therapy 12.11.1. Baclofen 12.11.2. Diazepam 12.11.3. Tizanidine 12.11.4. Dantrolene 12.12. India SPASTICITY TREATMENT Market Forecast, By Physical Therapy 12.12.1. Stretching 12.12.2. Strengthening Exercises 12.13. India SPASTICITY TREATMENT Market Forecast, By Drug Therapy 12.13.1. Baclofen 12.13.2. Diazepam 12.13.3. Tizanidine 12.13.4. Dantrolene 12.14. Japan SPASTICITY TREATMENT Market Forecast, By Physical Therapy 12.14.1. Stretching 12.14.2. Strengthening Exercises 12.15. Japan SPASTICITY TREATMENT Market Forecast, By Drug Therapy 12.15.1. Baclofen 12.15.2. Diazepam 12.15.3. Tizanidine 12.15.4. Dantrolene 12.16. South Korea SPASTICITY TREATMENT Market Forecast, By Physical Therapy 12.16.1. Stretching 12.16.2. Strengthening Exercises 12.17. South Korea SPASTICITY TREATMENT Market Forecast, By Drug Therapy 12.17.1. Baclofen 12.17.2. Diazepam 12.17.3. Tizanidine 12.17.4. Dantrolene 12.18. Australia SPASTICITY TREATMENT Market Forecast, By Physical Therapy 12.18.1. Stretching 12.18.2. Strengthening Exercises 12.19. Australia SPASTICITY TREATMENT Market Forecast, By Drug Therapy 12.19.1. Baclofen 12.19.2. Diazepam 12.19.3. Tizanidine 12.19.4. Dantrolene 12.20. ASEAN SPASTICITY TREATMENT Market Forecast, By Physical Therapy 12.20.1. Stretching 12.20.2. Strengthening Exercises 12.21. ASEAN SPASTICITY TREATMENT Market Forecast, By Drug Therapy 12.21.1. Baclofen 12.21.2. Diazepam 12.21.3. Tizanidine 12.21.4. Dantrolene 12.22. Rest of Asia Pacific SPASTICITY TREATMENT Market Forecast, By Physical Therapy 12.22.1. Stretching 12.22.2. Strengthening Exercises 12.23. Rest of Asia Pacific SPASTICITY TREATMENT Market Forecast, By Drug Therapy 12.23.1. Baclofen 12.23.2. Diazepam 12.23.3. Tizanidine 12.23.4. Dantrolene 12.24. Asia Pacific SPASTICITY TREATMENT Market Attractiveness Analysis 12.24.1. By Physical Therapy 12.24.2. By Drug Therapy 12.25. PEST Analysis 12.26. Key Trends 12.27. Key Developments 13. Middle East & Africa SPASTICITY TREATMENT Market Analysis 13.1. Key Findings 13.2. Middle East & Africa SPASTICITY TREATMENT Market Overview 13.3. Middle East & Africa SPASTICITY TREATMENT Market Value Share Analysis, By Physical Therapy 13.4. Middle East & Africa SPASTICITY TREATMENT Market Forecast, By Physical Therapy 13.4.1. Stretching 13.4.2. Strengthening Exercises 13.5. Middle East & Africa SPASTICITY TREATMENT Market Value Share Analysis, By Drug Therapy 13.6. Middle East & Africa SPASTICITY TREATMENT Market Forecast, By Drug Therapy 13.6.1. Baclofen 13.6.2. Diazepam 13.6.3. Tizanidine 13.6.4. Dantrolene 13.7. Middle East & Africa SPASTICITY TREATMENT Market Value Share Analysis, By Country 13.8. Middle East & Africa SPASTICITY TREATMENT Market Forecast, By Country 13.8.1. GCC Countries 13.8.2. South Africa 13.8.3. Nigeria 13.8.4. Egypt 13.8.5. Rest of Middle East & Africa 13.9. Middle East & Africa SPASTICITY TREATMENT Market Analysis, By Country 13.10. GCC Countries SPASTICITY TREATMENT Market Forecast, By Physical Therapy 13.10.1. Stretching 13.10.2. Strengthening Exercises 13.11. GCC Countries SPASTICITY TREATMENT Market Forecast, By Drug Therapy 13.11.1. Baclofen 13.11.2. Diazepam 13.11.3. Tizanidine 13.11.4. Dantrolene 13.12. South Africa SPASTICITY TREATMENT Market Forecast, By Physical Therapy 13.12.1. Stretching 13.12.2. Strengthening Exercises 13.13. South Africa SPASTICITY TREATMENT Market Forecast, By Drug Therapy 13.13.1. Baclofen 13.13.2. Diazepam 13.13.3. Tizanidine 13.13.4. Dantrolene 13.14. Nigeria SPASTICITY TREATMENT Market Forecast, By Physical Therapy 13.14.1. Stretching 13.14.2. Strengthening Exercises 13.15. Nigeria SPASTICITY TREATMENT Market Forecast, By Drug Therapy 13.15.1. Baclofen 13.15.2. Diazepam 13.15.3. Tizanidine 13.15.4. Dantrolene 13.16. Egypt SPASTICITY TREATMENT Market Forecast, By Physical Therapy 13.16.1. Stretching 13.16.2. Strengthening Exercises 13.17. Egypt SPASTICITY TREATMENT Market Forecast, By Drug Therapy 13.17.1. Baclofen 13.17.2. Diazepam 13.17.3. Tizanidine 13.17.4. Dantrolene 13.18. Rest of Middle East & Africa SPASTICITY TREATMENT Market Forecast, By Physical Therapy 13.18.1. Stretching 13.18.2. Strengthening Exercises 13.19. Rest of Middle East & Africa SPASTICITY TREATMENT Market Forecast, By Drug Therapy 13.19.1. Baclofen 13.19.2. Diazepam 13.19.3. Tizanidine 13.19.4. Dantrolene 13.20. Middle East & Africa SPASTICITY TREATMENT Market Attractiveness Analysis 13.20.1. By Physical Therapy 13.20.2. By Drug Therapy 13.21. PEST Analysis 13.22. Key Trends 13.23. Key Developments 14. South America SPASTICITY TREATMENT Market Analysis 14.1. Key Findings 14.2. South America SPASTICITY TREATMENT Market Overview 14.3. South America SPASTICITY TREATMENT Market Value Share Analysis, By Physical Therapy 14.4. South America SPASTICITY TREATMENT Market Forecast, By Physical Therapy 14.4.1. Stretching 14.4.2. Strengthening Exercises 14.5. South America SPASTICITY TREATMENT Market Value Share Analysis, By Drug Therapy 14.6. South America SPASTICITY TREATMENT Market Forecast, By Drug Therapy 14.6.1. Baclofen 14.6.2. Diazepam 14.6.3. Tizanidine 14.6.4. Dantrolene 14.7. South America SPASTICITY TREATMENT Market Value Share Analysis, By Country 14.8. South America SPASTICITY TREATMENT Market Forecast, By Country 14.8.1. Brazil 14.8.2. Colombia 14.8.3. Argentina 14.8.4. Rest of South America 14.9. South America SPASTICITY TREATMENT Market Analysis, By Country 14.10. Brazil SPASTICITY TREATMENT Market Forecast, By Physical Therapy 14.10.1. Stretching 14.10.2. Strengthening Exercises 14.11. Brazil SPASTICITY TREATMENT Market Forecast, By Drug Therapy 14.11.1. Baclofen 14.11.2. Diazepam 14.11.3. Tizanidine 14.11.4. Dantrolene 14.12. Colombia SPASTICITY TREATMENT Market Forecast, By Physical Therapy 14.12.1. Stretching 14.12.2. Strengthening Exercises 14.13. Colombia SPASTICITY TREATMENT Market Forecast, By Drug Therapy 14.13.1. Baclofen 14.13.2. Diazepam 14.13.3. Tizanidine 14.13.4. Dantrolene 14.14. Argentina SPASTICITY TREATMENT Market Forecast, By Physical Therapy 14.14.1. Stretching 14.14.2. Strengthening Exercises 14.15. Argentina SPASTICITY TREATMENT Market Forecast, By Drug Therapy 14.15.1. Baclofen 14.15.2. Diazepam 14.15.3. Tizanidine 14.15.4. Dantrolene 14.16. Rest of South America SPASTICITY TREATMENT Market Forecast, By Physical Therapy 14.16.1. Stretching 14.16.2. Strengthening Exercises 14.17. Rest of South America SPASTICITY TREATMENT Market Forecast, By Drug Therapy 14.17.1. Baclofen 14.17.2. Diazepam 14.17.3. Tizanidine 14.17.4. Dantrolene 14.18. South America SPASTICITY TREATMENT Market Attractiveness Analysis 14.18.1. By Physical Therapy 14.18.2. By Drug Therapy 14.19. PEST Analysis 14.20. Key Trends 14.21. Key Developments 15. Company Profiles 15.1. Market Share Analysis, By Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players By price, presence, market share, Drug Therapy, and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A By Regions, Investment and Drug Therapy 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Codman & Shurtleff Inc 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Development Footprint 15.3.2. Medtronic, Inc 15.3.3. InMed Pharmaceuticals, Inc 15.3.4. Ipsen 15.3.5. Orient Pharma Co, Ltd 15.3.6. Taj Pharmaceuticals 15.3.7. MediciNova, Inc 15.3.8. Sanofi 15.3.9. Genentech 15.3.10. F.Hoffmann-La Roche Ltd 15.3.11. GlaxoSmithKline plc 15.3.12. Allergan 15.3.13. Pfizer 15.3.14. UCB Pharma 15.3.15. Johnson & Johnson Services 15.3.16. Sun Pharmaceuticals 15.3.17. Novartis AG 15.3.18. Teva Pharmaceuticals 15.3.19. Merz Pharma 15.3.20. Revance Therapeutics 15.3.21. Acorda Therapeutics 15.3.22. Orient Pharma 15.3.23. GW Pharmaceuticals

About This Report

Report ID 81891
Category Healthcare
Published Date February 2021
Updated Date Oct 2021
Contact Us